Changes in attitudes among Japanese patients after Pharmacist Law revision

Naomi Iihara, Yuji Kurosaki, Chika Miyoshi, Kiyo Takabatake, Shushi Morita

Research output: Contribution to journalArticle

Abstract

Objective: To assess changes in patients' perception of their medications and their adherence to regimens after enactment of the Japanese Pharmacist Law revision of 1997, which stipulated provision of drug information to patients as one of the principal duties of pharmacists. Setting: A university hospital in Japan. Method: Comparison of cross sectional analyses between two time periods: shortly after enactment of the Pharmacist Law revision and about a half-decade later. Main Outcome Measure: Patient's knowledge of the medications, anxiety level, individual beliefs regarding taking medications without anxiety, and adherence to the medication regimens. Results: There were 141 and 151 patients who participated during each period, respectively. The proportion of non-adherent patients significantly decreased from 68.8 to 53.6% (P = 0.008). Multiple logistic regression analysis indicated that the features of the intentionally non-adherent patients have changed; they have switched from persons who lack general comprehension about the medications (P = 0.01), ones who place an importance on knowing the side effects (P = 0.04), or who place no value on mutual reliance on their doctors (P = 0.03) into persons who place no value on understanding the purpose of taking their medications (P = 0.04) or who place value on multiple items to take medications without anxiety (P = 0.03), i.e., supposedly people who prefer thinking about their drug therapy from their own point of view based on comprehension of their disease and medications. Conclusions: The rapid progression of drug information disclosure after enactment of the Pharmacist Law revision has likely resulted in drastic changes in patients' perception of their medications and led to improvements in medication adherence.

Original languageEnglish
Pages (from-to)258-264
Number of pages7
JournalPharmacy World and Science
Volume30
Issue number3
DOIs
Publication statusPublished - Jun 2008

Fingerprint

Pharmacists
Drug therapy
Medication Adherence
Regression analysis
Pharmaceutical Preparations
Logistics
Anxiety
Patient Medication Knowledge
Disclosure
Japan
Cross-Sectional Studies
Logistic Models
Regression Analysis
Outcome Assessment (Health Care)
Drug Therapy

Keywords

  • Administrative pharmacy
  • Drug information
  • Healthcare reform
  • Information
  • Japan
  • Patient compliance
  • Patient perceptions
  • Service provision

ASJC Scopus subject areas

  • Chemistry(all)
  • Pharmaceutical Science
  • Pharmacology

Cite this

Changes in attitudes among Japanese patients after Pharmacist Law revision. / Iihara, Naomi; Kurosaki, Yuji; Miyoshi, Chika; Takabatake, Kiyo; Morita, Shushi.

In: Pharmacy World and Science, Vol. 30, No. 3, 06.2008, p. 258-264.

Research output: Contribution to journalArticle

Iihara, Naomi ; Kurosaki, Yuji ; Miyoshi, Chika ; Takabatake, Kiyo ; Morita, Shushi. / Changes in attitudes among Japanese patients after Pharmacist Law revision. In: Pharmacy World and Science. 2008 ; Vol. 30, No. 3. pp. 258-264.
@article{fa0f148e49d74ba4be23f551d8912cfb,
title = "Changes in attitudes among Japanese patients after Pharmacist Law revision",
abstract = "Objective: To assess changes in patients' perception of their medications and their adherence to regimens after enactment of the Japanese Pharmacist Law revision of 1997, which stipulated provision of drug information to patients as one of the principal duties of pharmacists. Setting: A university hospital in Japan. Method: Comparison of cross sectional analyses between two time periods: shortly after enactment of the Pharmacist Law revision and about a half-decade later. Main Outcome Measure: Patient's knowledge of the medications, anxiety level, individual beliefs regarding taking medications without anxiety, and adherence to the medication regimens. Results: There were 141 and 151 patients who participated during each period, respectively. The proportion of non-adherent patients significantly decreased from 68.8 to 53.6{\%} (P = 0.008). Multiple logistic regression analysis indicated that the features of the intentionally non-adherent patients have changed; they have switched from persons who lack general comprehension about the medications (P = 0.01), ones who place an importance on knowing the side effects (P = 0.04), or who place no value on mutual reliance on their doctors (P = 0.03) into persons who place no value on understanding the purpose of taking their medications (P = 0.04) or who place value on multiple items to take medications without anxiety (P = 0.03), i.e., supposedly people who prefer thinking about their drug therapy from their own point of view based on comprehension of their disease and medications. Conclusions: The rapid progression of drug information disclosure after enactment of the Pharmacist Law revision has likely resulted in drastic changes in patients' perception of their medications and led to improvements in medication adherence.",
keywords = "Administrative pharmacy, Drug information, Healthcare reform, Information, Japan, Patient compliance, Patient perceptions, Service provision",
author = "Naomi Iihara and Yuji Kurosaki and Chika Miyoshi and Kiyo Takabatake and Shushi Morita",
year = "2008",
month = "6",
doi = "10.1007/s11096-007-9171-6",
language = "English",
volume = "30",
pages = "258--264",
journal = "International Journal of Clinical Pharmacy",
issn = "2210-7703",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Changes in attitudes among Japanese patients after Pharmacist Law revision

AU - Iihara, Naomi

AU - Kurosaki, Yuji

AU - Miyoshi, Chika

AU - Takabatake, Kiyo

AU - Morita, Shushi

PY - 2008/6

Y1 - 2008/6

N2 - Objective: To assess changes in patients' perception of their medications and their adherence to regimens after enactment of the Japanese Pharmacist Law revision of 1997, which stipulated provision of drug information to patients as one of the principal duties of pharmacists. Setting: A university hospital in Japan. Method: Comparison of cross sectional analyses between two time periods: shortly after enactment of the Pharmacist Law revision and about a half-decade later. Main Outcome Measure: Patient's knowledge of the medications, anxiety level, individual beliefs regarding taking medications without anxiety, and adherence to the medication regimens. Results: There were 141 and 151 patients who participated during each period, respectively. The proportion of non-adherent patients significantly decreased from 68.8 to 53.6% (P = 0.008). Multiple logistic regression analysis indicated that the features of the intentionally non-adherent patients have changed; they have switched from persons who lack general comprehension about the medications (P = 0.01), ones who place an importance on knowing the side effects (P = 0.04), or who place no value on mutual reliance on their doctors (P = 0.03) into persons who place no value on understanding the purpose of taking their medications (P = 0.04) or who place value on multiple items to take medications without anxiety (P = 0.03), i.e., supposedly people who prefer thinking about their drug therapy from their own point of view based on comprehension of their disease and medications. Conclusions: The rapid progression of drug information disclosure after enactment of the Pharmacist Law revision has likely resulted in drastic changes in patients' perception of their medications and led to improvements in medication adherence.

AB - Objective: To assess changes in patients' perception of their medications and their adherence to regimens after enactment of the Japanese Pharmacist Law revision of 1997, which stipulated provision of drug information to patients as one of the principal duties of pharmacists. Setting: A university hospital in Japan. Method: Comparison of cross sectional analyses between two time periods: shortly after enactment of the Pharmacist Law revision and about a half-decade later. Main Outcome Measure: Patient's knowledge of the medications, anxiety level, individual beliefs regarding taking medications without anxiety, and adherence to the medication regimens. Results: There were 141 and 151 patients who participated during each period, respectively. The proportion of non-adherent patients significantly decreased from 68.8 to 53.6% (P = 0.008). Multiple logistic regression analysis indicated that the features of the intentionally non-adherent patients have changed; they have switched from persons who lack general comprehension about the medications (P = 0.01), ones who place an importance on knowing the side effects (P = 0.04), or who place no value on mutual reliance on their doctors (P = 0.03) into persons who place no value on understanding the purpose of taking their medications (P = 0.04) or who place value on multiple items to take medications without anxiety (P = 0.03), i.e., supposedly people who prefer thinking about their drug therapy from their own point of view based on comprehension of their disease and medications. Conclusions: The rapid progression of drug information disclosure after enactment of the Pharmacist Law revision has likely resulted in drastic changes in patients' perception of their medications and led to improvements in medication adherence.

KW - Administrative pharmacy

KW - Drug information

KW - Healthcare reform

KW - Information

KW - Japan

KW - Patient compliance

KW - Patient perceptions

KW - Service provision

UR - http://www.scopus.com/inward/record.url?scp=42249087780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42249087780&partnerID=8YFLogxK

U2 - 10.1007/s11096-007-9171-6

DO - 10.1007/s11096-007-9171-6

M3 - Article

C2 - 17960491

AN - SCOPUS:42249087780

VL - 30

SP - 258

EP - 264

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 2210-7703

IS - 3

ER -